Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-05

Clinical Trial Results: Mechanisms of Smell Improvement With Dupilumab. [Phase 4]

View source ↗

Summary

Phase 4 trial results examining mechanisms of smell improvement with dupilumab in chronic rhinosinusitis with nasal polyps.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dupilumab (dupilumab)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 4 | Status: COMPLETED | Results posted: 2026-08-05